To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Hellman & Friedman’s PPD shows PE growth in action
Pharmaceutical Product Development goes public eight years after H&F and Carlyle completed its buyout.
